SERD

DRUG2 trials

Sponsors

Fudan University

Conditions

Breast CancerMetastatic Cancer

Phase 2

Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

Fudan UniversityBreast Cancer, Metastatic Cancer

Start: 2020-05-01End: 2025-04-01Target: 319Updated: 2022-07-26

Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02

RecruitingNCT05205200

Fudan UniversityBreast Cancer, Metastatic Cancer

Start: 2022-06-06End: 2026-08-01Target: 338Updated: 2024-02-08

Related Papers

Abstract PO1-15-07: Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2- breast cancer: a sub-study of the MULAN umbrella trial

Cancer Research2024-05-02